Articles related to TESTING/LABS

Explore the groundbreaking diagnostic capabilities of the p-tau217 test in Alzheimer’s disease, demonstrating high accuracy in detecting pathological markers and offering a new horizon in non-invasive diagnostic strategies.

Physicians must comprehend the detection windows for THC and its metabolites, crucial for advising patients on cannabis use and interpreting drug test results. Factors such as dosage, frequency, and method of consumption directly impact THC’s longevity in the system.

With a negative predictive value of 97%, the new breath test for colorectal cancer represents a significant advancement in non-invasive cancer diagnostics.

Explore this comprehensive guide on evaluating a low anion gap and enhance your diagnostic capabilities. Don’t miss out on the opportunity to learn more.

Discover how Labcorp’s new ATN Profile can revolutionize your approach to diagnosing Alzheimer’s disease.

Discover how the FDA-approved Invitae’s Common Hereditary Cancers Panel can enhance your approach to early cancer detection and personalized treatment planning.